npj Imaging will publish cutting-edge research related to the design and development of new imaging tools, the use of these tools to better-understand (patho)physiology, and their implementation in clinical research.

Dr. Witney will advance the journal’s mission of showcasing impactful and high-quality content on all aspects of imaging research across scales and the translational pipeline.

“Imaging provides a window for us to peer into the cells and living systems in order to better-understand how they function and npj Imaging will provide an international platform to showcase these discoveries. Given the interdisciplinary nature of our field, we accept manuscripts that represent this diversity: from the design and synthesis of new probes, to their use in unravelling biological mechanisms,” said Tim.

Dr. Witney joined King's College London in 2018 after starting his group at University College London under a Royal Society & Wellcome Trust Sir Henry Dale Fellowship. Tim is currently a Reader in Molecular Imaging and Wellcome Trust Senior Research Fellow. He serves on the Executive Board of the European Society for Molecular Imaging and is the Program Co-Chair for the World Molecular Imaging Congress.

“I want to build an imaging journal that looks not at where we are as a community but where we’re going. Combining both bio- and medical-imaging will be challenging, but the opportunity to highlight innovative research from cells to patients is something I’m looking forward to,” Tim said.

npj Imaging  is part of the prestigious Nature Portfolio, where preeminent scientists and global partners collaborate to publish high-quality open access research.